McKesson stock trades near 52-week high after strong quarter
π McKesson reported USD 105.38 billion in revenue for the quarter ended August 5, 2026, representing a 7.7 percent increase from the prior year.
π° The company delivered adjusted EPS of USD 9.93, beating the consensus estimate of USD 9.56 and showing a year-over-year gain of USD 1.67 per share.
π Stock price reached USD 907.35 on Friday, trading near its 52-week high of USD 999.00 and above both key moving averages.
π― Management provided FY 2027 EPS guidance between USD 44.2 and USD 45.0, aligning closely with analyst expectations of USD 44.65.
π’ As a leading healthcare distributor, McKesson continues to leverage its massive scale, evidenced by over USD 105 billion in quarterly revenue.
π The company maintains a net margin of 1.12 percent, which translates into substantial market capitalization exceeding USD 105 billion.
- McKesson beat analyst consensus estimates with adjusted EPS of USD 9.93 versus the expected USD 9.56 for the quarter ended August 5, 2026.
- Revenue grew 7.7 percent year-over-year to reach USD 105.38 billion, demonstrating continued top-line expansion in the healthcare distribution sector.
- The stock price rallied to USD 907.35, trading near its 52-week high of USD 999.00 and validating the market's positive reaction to the strong quarterly results.
- Management provided FY 2027 EPS guidance of USD 44.2 to USD 45.0, which aligns well with external analyst expectations of USD 44.65 for the current fiscal year.